Privileged Talks are exclusive conversations with Top European policy makers. The aim of this initiative is to meet the increasingly urgent need to broaden and deepen the discussion of these issues.
Bringing together the international protagonists of the heath system, the talks were created to become an exclusive opportunity for meeting and debating with the policy makers of the European healthcare system.
The FDA is also instituting major changes to the US medical device regulations.
The meeting will focus on the European Commission's Regulation of medical devices and how they will change access to technological innovation in Europe.
The EU Medical Devices Regulation ((EU) 2017/745) will come into force on 26 May 2020.
A multi-stakeholder dialogue with:
The participation fee is € 500 (+VAT, if applicable).
An early bird fee of € 400 (+VAT, if applicable) will be granted to participants that will register before 14 November 2019.